Plurilock - CEO, Ian Paterson.
CEO, Ian Paterson.
Source: Plurilock.
  • Plurilock Security (PLUR) has received a US$217,000 order from a California state retirement fund manager
  • The company will provide the fund manager with license renewals and maintenance support on several VMware products
  • Since April 1, 2021, Plurilock has announced US$7.6 million in sales from signed orders and contracts
  • Plurilock provides identity-centric cybersecurity for today’s workforces
  • Plurilock Security (PLUR) is up by 4.17 per cent and is currently trading at $0.50 per share

Plurilock Security (PLUR) has received a US$217,000 order from a California state retirement fund manager.

As per the terms of the order, the company will supply the fund manager with license renewals and maintenance support on several VMware products that provide virtual desktop infrastructure, server visualization, business continuity and disaster recovery solutions.

Over the last three years, U.S. government organizations have been hit with 246 ransomware attacks impacting over 173 million people and costing an estimated US$52.88 billion, according to American City & County.

The U.S. Government Accountability Office stated that, as of 2018, about 106 million people participate in employer-sponsored defined contribution retirement plans, but that the Department of Labor has not clarified plan administrators’ responsibility for mitigating cybersecurity risks.

Since April 1, 2021, Plurilock has announced US$7.6 million in sales from signed orders and contracts.

Plurilock provides identity-centric cybersecurity for today’s workforces.

Plurilock Security (PLUR) is up by 4.17 per cent and is currently trading at $0.50 per share as of 10:01 am ET.

More From The Market Online

Liberty Defense expands its international customer base

Liberty Defense Holdings (TSXV:SCAN), a provider of artificial intelligence technologies, expands its international customer base.

Unsung profits: Three microcap stocks with a strong case for value

A key factor behind picking winning microcap value stocks is identifying dislocations between company performance and market perception.

Theralase advances cancer research after private placement

Theralase Technologies (TSXV:TLT) closes a non-brokered private placement offering of 4.1 million shares for gross proceeds of C$750,200.